2026年 议程
Cambridge Venture, Innovation & Partnering (VIP)主办第三届
Bio-IT World Venture, Innovation & Partnering
Connect Capital and Science to Shape the Future
连结资本与科学，塑造未来
2026年5月19日
第三届 Bio-IT World Venture, Innovation & Partnering Conference（2026年5月19日）将作为第25届 Bio-IT World Conference & Expo的一环，提供推动下一代生物技术和精准医疗的投资者、企业领导者和企业家提供一个高阶平台。这场小规模活动将邀集来自创投、私募股权、企业创投部门、成长阶段公司和制药公司的最高管理阶层领导者齐聚于此。2026 年议程节目的重点在人工智慧驱动的药物发现、平台与产品投资模式、不断进化的并购和合作策略、IPO和私募流动性途径，以及影响资本配置的监管变化。各节目单元旨在为投资者提供有关市场动态、风险调整回报和可扩展创新策略的清晰见解。透过坦诚的讨论、炉边谈话和精心策划的小组讨论，与会者将可探索资本如何分配、创新管道的发展方向以及如何识别长期赢家。除了以投资者为中心的意见交流之外，藉由超过 150 场展览、11 个科学轨道以及 30 多个国家的全球合作伙伴，以拓宽他们的市场视野。
Tuesday, May 19
Registration and Networking Coffee
Organizer's Welcome Remarks
MARKET OVERVIEW: Sponsored Presentation (Opportunity Available)
Funding the Modern Pipeline: Capital Strategy across Biology, Technology, and Informatics
Rebecca Stevenson, CFO, Souffle Thereapeutics
This panel explores how capital is being strategically deployed across biology, technology, and informatics. Panelists will discuss how investors are structuring and targeting funding to support drug discovery.
Leadership at the Cutting Edge: Innovation, Strategy & Biotech’s Next Frontier
Michael Nally, CEO, Generate:Biomedicines
This keynote interview with Mike Nally, CEO of Generate:Biomedicines and CEO-Partner at Flagship Pioneering, explores his leadership in advancing generative biology and programmable protein therapeutics. Since joining in 2021, Nally has driven major partnerships, financing-rounds exceeding $750 million, and clinical progress, positioning Generate:Biomedicines at the forefront of AI-driven drug discovery.
Networking Coffee Break
Chairperson's Remarks
Driving Innovation Together: The New Rules of VC, Pharma & Industry Leader Collaboration
Rana Lonnen, General Partner, Science Capital
This panel explores how venture capital, pharma, and industry leaders are reshaping collaboration to accelerate biotech innovation. Panelists will discuss new approaches to funding, partnerships, and technology adoption that drive drug discovery, scale emerging companies, and create more effective pathways from lab-to-market.
Sponsored Presentation (Opportunity Available)
Roundtable Discussions are informal, moderated discussions, allowing participants to exchange ideas and experiences and develop future collaborations around a focused topic. Each discussion will be led by a facilitator who keeps the discussion on track and the group engaged. To get the most out of this format, please come prepared to share examples from your work, be a part of a collective problem-solving session, and participate in active idea sharing.
Innovation in Science & Business Models Advancing Drug Discovery
William T. Mayo, Founder, Wellfleet Advisors
This panel brings together leaders from pharma, biotech, AI, and venture investing to explore how innovative science and business models are transforming drug discovery. Panelists will share insights on leveraging advanced technologies, data-driven R&D, and strategic partnerships to accelerate pipeline development, scale emerging companies, and create new investment opportunities-providing actionable takeaways for investors, entrepreneurs, and CEOs driving the next wave of drug discovery innovation.
Sponsored Presentation (Opportunity Available)
Engineering Access: Scalable Genomics, Technology & the Future of Medicine
Michael Chambers, Founding CEO, Aldevron
This keynote fireside will spotlight the leadership journey behind building and scaling one of genomic medicine’s most critical infrastructure companies. From founding a university lab start-up to leading its growth into a global platform powering cell and gene therapies and a landmark $9.6 billion exit, the conversation will unpack the decisions, discipline, and long-term strategy required to scale enduring biotech-companies in a capital-intensive market.The discussion will conclude with Morgan and Michael highlighting where they see the greatest opportunities in biotech today and providing a forward-looking perspective on the problems to be solved and areas of significant unmet clinical need.
At the Helm: Emerging and Established CEOs in Debate on Building Companies
Joanne L. Viney, PhD, Co-Founder & President & CEO, Seismic Therapeutic
This panel brings together accomplished CEOs from biotech, digital biology, and drug discovery companies for a dynamic debate on building and scaling innovative organizations. Panelists will explore leadership challenges, strategic decision-making, and balancing growth with innovation, offering investors, entrepreneurs, and executives practical insights into what it takes to lead successful companies across the life sciences and tech-enabled drug discovery landscape.
Sponsored Presentation (Opportunity Available)
The Future of Lab Funding: Building Stronger Pathways between Academia, Capital, and Spinouts
Michael Langer, Co-Founder and Managing Partner, T.Rx Capital
As biotech and precision medicine converge with advanced technology, the next generation of breakthrough companies is being born in academia. This executive-level discussion explores how investors, foundations, and institutions can unlock novel university science, modernize lab funding models, and build scalable pathways from discovery to venture-backed spinout, aligning capital, talent, and strategy to accelerate impact in drug discovery.
PLENARY KEYNOTE PROGRAM
Rare Conversations: Explorations of the Research, Funding, and Advocacy for Rare Diseases
Catherine Brownstein, PhD, Manager, Molecular Genomics Core Facility, Boston Children's Hospital; Scientific Director, Manton Center for Orphan Disease Research Gene Discovery Core; Assistant Professor, Harvard Medical School
In a unique plenary series of intimate conversations, we will explore the models, drivers, and challenges facing rare disease research. By uniting leaders in precision medicine, bioinformatics, national rare-disease infrastructure, and real-world legislative advocacy, we will give attendees an expansive, cross-disciplinary view of what’s required to deliver faster, more accurate, and more equitable rare-disease cures.
Welcome Reception in the Exhibit Hall with Poster Viewing
The Bio-IT Kickoff Reception is a reunion-reconnect with friends, explore cutting-edge research, and celebrate innovation! Enjoy poster presentations, networking, and vote for the Best of Show and Poster awards.
Close of Summit
Close of Day
* 活动内容有可能不事先告知作更动及调整。